Medtronic (MDT) Q1 FY2025 earnings: revenue $7.9 billion, up 2.8% on the year
Medtronic plc (MDT) reported revenue of $7.9 billion for Q1 FY2025, the quarter ended 26 July 2024, up 2.8% on the same quarter a year earlier. Net income was $1.0 billion, up 31.7% on the year, and diluted earnings per share $0.80. The figures are the company's own, from the 10-Q it filed with the SEC on 27 August 2024.
Revenue
$7.9 billion
+2.8% on the year · -7.8% on the quarter
Q2 FY2023Q1 FY2025
Operating margin
16.1%
16.5% a year earlier
Q2 FY2023Q1 FY2025
Net income
$1.0 billion
+31.7% on the year · +59.3% on the quarter
Q2 FY2023Q1 FY2025
Diluted EPS
$0.80
+35.6% on the year · +63.3% on the quarter
Q2 FY2023Q1 FY2025
this quarterthe same quarter a year earlierHover a bar for its figure.
Income statement (profit and loss)
$ million
Q1 FY2025
Q4 FY2024
Q1 FY2024
On the quarter
On the year
Last 8 quarters
Revenue
7,915
8,589
7,702
-7.8%
+2.8%
Cost of revenue
2,761
3,045
2,628
-9.3%
+5.1%
Gross profit
5,154
5,544
5,074
-7.0%
+1.6%
Gross margin
65.1%
64.5%
65.9%
Research and development
676
674
668
+0.3%
+1.2%
Selling, general and administrative
2,655
2,764
2,613
-3.9%
+1.6%
Operating income
1,278
1,053
1,268
+21.4%
+0.8%
Operating margin
16.1%
12.3%
16.5%
Interest expense
167
203
148
-17.7%
+12.8%
Pre-tax income
1,268
856
1,196
+48.1%
+6.0%
Income tax
220
196
400
+12.2%
-45.0%
Effective tax rate
17.4%
22.9%
33.4%
Net income
1,042
654
791
+59.3%
+31.7%
Net margin
13.2%
7.6%
10.3%
Diluted EPS
$0.80
$0.49
$0.59
+63.3%
+35.6%
$ million except per share. Read moreFourth quarters are the year less the first three quarters. Free cash flow is operating cash flow less capital expenditure; the effective tax rate is income tax over pre-tax income; margins are the line over revenue. Gross profit is revenue less cost of revenue, and operating income is revenue less the company's own total costs, where the statement does not print those lines. Those four are arithmetic on the filed numbers; everything else is as filed. Money is in $ million as the company files it, or in $ billion by the switch above the tables; per share figures and share counts are as they are.
Cash flow
$ million
Q1 FY2025
Q4 FY2024
Q1 FY2024
On the quarter
On the year
Last 8 quarters
Operating cash flow
986
2,777
875
-64.5%
+12.7%
Capital expenditure
520
426
354
+22.1%
+46.9%
Free cash flow
466
2,351
521
-80.2%
-10.6%
Free cash flow margin
5.9%
27.4%
6.8%
Cash from investing
-259
-696
-539
Cash from financing
-731
-2,359
-501
Depreciation and amortisation
662
654
672
+1.2%
-1.5%
Share-based compensation
83.0
89.0
73.0
-6.7%
+13.7%
Buybacks
2,492
1,628
152
+53.1%
+1,539.5%
Dividends paid
898
913
918
-1.6%
-2.2%
Dividend per share
$0.70
n/a
$0.69
+1.4%
Diluted shares, weighted
1,296m
1,325m
1,334m
-2.2%
-2.8%
Shares outstanding at period end
1,282m
1,311m
1,330m
-2.2%
-3.6%
Cash flow lines for the quarter; where the company files them year to date, the quarter is the difference between two filings.
Balance sheet
$ million
Q1 FY2025
Q4 FY2024
Q1 FY2024
On the quarter
On the year
Last 8 quarters
Shareholders' equity
47,947
50,214
51,178
-4.5%
-6.3%
Non-controlling interest
213
206
188
+3.4%
+13.3%
Debt
27,865
25,024
24,982
+11.4%
+11.5%
Operating lease liabilities
n/a
840
n/a
Finance lease liabilities
52.0
55.0
57.0
-5.5%
-8.8%
Other liabilities
13,672
13,642
14,371
+0.2%
-4.9%
Total liabilities and equity
89,749
89,981
90,776
-0.3%
-1.1%
Fixed assets
6,282
6,131
5,665
+2.5%
+10.9%
Goodwill
41,084
40,986
41,436
+0.2%
-0.8%
Intangible assets
12,819
13,225
14,434
-3.1%
-11.2%
Investments
6,532
6,721
6,537
-2.8%
-0.1%
Cash and equivalents
1,311
1,284
1,339
+2.1%
-2.1%
Receivables
6,011
6,128
5,806
-1.9%
+3.5%
Inventory
5,414
5,217
5,668
+3.8%
-4.5%
Other assets
10,296
10,289
9,891
+0.1%
+4.1%
Total assets
89,749
89,981
90,776
-0.3%
-1.1%
Questions
What was Medtronic's revenue in Q1 FY2025?
Medtronic (MDT) reported revenue of $7.9 billion for Q1 FY2025, the quarter ended 26 July 2024, up 2.8% on the same quarter a year earlier.
How much did Medtronic earn in Q1 FY2025?
Net income for Q1 FY2025 was $1.0 billion, up 31.7% on the year, and diluted earnings per share $0.80.
When did Medtronic report Q1 FY2025 results?
Medtronic filed its 10-Q for the quarter ended 26 July 2024 with the SEC on 27 August 2024.
Each quarter as filed, linked to its filing. Read more* The fourth quarter is the full year less the first three quarters, because the company files the year and not the quarter on its own. A fourth quarter's EPS, and its diluted share count where shown, are from the company's results press release for that quarter, checked against the company's filed figures or a second data source. Money is in $ million as the company files it, or in $ billion by the switch above the tables; per share figures and the share count are as they are. Free cash flow is operating cash flow less capital expenditure; the effective tax rate is income tax over pre-tax income; margins are the line over revenue. Gross profit is revenue less cost of revenue, and operating income is revenue less the company's own total costs, where the statement does not print those lines. Cash flow lines filed year to date are the difference between two filings. Shares outstanding are at the period end where the balance sheet tags them, otherwise the count on the filing's cover page. A derived fourth-quarter EPS is left blank when a split in the year makes the arithmetic meaningless.
10-Q for the period ended 26 July 2024, filed 27 August 2024: the filing.